Genmab in advanced talks to buy Dutch drugmaker Merus - Bloomberg
PositiveFinancial Markets

Genmab is reportedly in advanced discussions to acquire the Dutch drugmaker Merus, a move that could significantly enhance its portfolio in the biopharmaceutical sector. This acquisition is important as it reflects Genmab's strategy to expand its capabilities and offerings in innovative therapies, potentially leading to new treatments for patients and strengthening its position in the competitive market.
— Curated by the World Pulse Now AI Editorial System